Vitamin D and ischaemic heart disease

Area of Science:

• Cardiology
• Endocrinology
• Nutritional Science

Background:

• Vitamin D has been investigated as a potential risk factor for ischemic heart disease.
• The role of vitamin D metabolites in cardiovascular health requires further elucidation.

Purpose of the Study:

• To investigate the relationship between serum levels of 25-hydroxy-cholecalciferol (25-HCC), the major circulating vitamin D metabolite, and ischemic heart disease.
• To compare 25-HCC levels in patients with myocardial infarction and angina pectoris to those in normal individuals.

Main Methods:

• Serum 25-HCC levels were measured in patients with acute myocardial infarction, angina pectoris, and in a control group of normal persons.
• Levels were assessed during the initial days of myocardial infarction and compared across groups.
• Correlations with serum cholesterol, glycerides, calcium, and magnesium were examined.

Main Results:

• Serum 25-HCC levels did not fluctuate significantly in the first four days following acute myocardial infarction.
• No significant differences were found in serum 25-HCC levels between patients with myocardial infarction, angina pectoris, and normal individuals.
• Serum calcium and magnesium were low in all patients, with calcium decreasing further during acute myocardial infarction and parathyroid hormone increasing.

Conclusions:

• Patients with ischemic heart disease do not appear to ingest or produce elevated amounts of vitamin D.
• The observed low calcium and magnesium levels in heart patients warrant further investigation.
• Vitamin D status, as indicated by 25-HCC levels, is unlikely to be a primary risk factor for ischemic heart disease in this cohort.